Directa Plus PLC Result of General Meeting
July 26 2024 - 11:33AM
RNS Regulatory News
RNS Number : 0863Y
Directa Plus PLC
26 July 2024
26 July 2024
Directa Plus plc
("Directa Plus", the
"Group" or the "Company")
Result of
General Meeting
Directa Plus (AIM: DCTA), a leading producer
and supplier of graphene nanoplatelets based products for use in
consumer and industrial markets, is pleased to
announce the results of the Company resolutions put to Shareholders
at the General Meeting, in connection with the Company's Annual
Report and Accounts, held earlier today. All resolutions, set out
in the Notice of General Meeting, were passed by the requisite
majority. The results of the poll for each resolution will be
available shortly on the Company's website at:
http://www.directa-plus.com/
For
further information, please contact:
Directa Plus
plc
|
+39 02
36714458
|
Giulio Cesareo, CEO
|
|
Giorgio Bonfanti, CFO
|
|
|
|
Cavendish
Capital Markets Limited (Nominated Adviser and Joint
Broker)
|
+44 131 220
6939
|
Neil McDonald
|
|
Adam Rae
|
|
|
|
Singer Capital
Markets Securities Limited (Joint Broker)
|
+44 20 7496
3069
|
Rick Thompson
|
|
Phil Davies
|
|
|
|
Alma Strategic
Communications (Financial PR Adviser)
|
+44 20 3405
0205
|
Justine James
|
|
Hannah Campbell
|
|
Kinvara Verdon
|
|
Notes to
Editors
Directa Plus (www.directa-plus.com) is one of
the largest producers and suppliers of graphene-based products for
use in consumer and industrial markets. The Company's graphene
manufacturing capability uses proprietary patented technology based
on a plasma super expansion process. Starting from natural
graphite, each step of Directa Plus' production process -
expansion, exfoliation and drying - creates graphene-based
materials and hybrid graphene materials ready for a variety of uses
and available in various forms such as powder, liquid and
paste.
This proprietary production process uses a
physical process, rather than a chemical process, to process
graphite into pristine graphene nanoplatelets, which enables
Directa Plus to offer a sustainable, nontoxic product, without
unwanted by-products.
Directa Plus' products are made of hybrid
graphene materials and graphene nano-platelets. The products
(marketed as G+(R)) have multiple applications due to its
properties. These G+(R) products can be categorised into various
families, with different products being suitable for specific
practical applications.
Directa Plus was established in 2005 and is
based in Lomazzo (Como, Italy) and has been listed on the AIM
market of the London Stock Exchange since May 2016. Directa Plus
holds the Green Economy Mark from London Stock Exchange which
recognises companies that contribute to the global green
economy.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
ROMUNOVRSAUBUAR
Directa Plus (LSE:DCTA)
Historical Stock Chart
From Nov 2024 to Dec 2024
Directa Plus (LSE:DCTA)
Historical Stock Chart
From Dec 2023 to Dec 2024